This technical article describes a novel ionic liquid technology that offers a new way to improve bioavailability lipid-based formulations and potentially reduce patients’ daily dose requirements. This technology is based on lipid-like counter-ion salts to improve the solubility of lipid-based liquid, semisolid, and multiparticulate formulations. These ionic liquids offer formulators the potential to reduce absorption variability, decrease excipient levels, and reduce bill burden.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.